News

Government of Canada confirmed Canada's commitment to Nasa Lunar Gateway program

The government of Canada confirmed today, Thursday, February 28, 2019, Canada's commitment to the Lunar Gateway space mission led by the United States, to give Canada's space program a new momentum. The Prime Minister of Canada Justin Trudeau announced historic investments in Canada’s space program. The Government of Canada will invest $2.05 billion over 24 years for Canada's space program. It will help grow innovative Canadian companies of all sizes by supporting the development of new digital and artificial intelligence-based technologies, and by opening new markets for Canadian businesses (Prime Minister's Office).

This investment will also give Canadian astronauts the opportunity to participate in missions to space and our scientists a chance to conduct cutting-edge research that cannot be done on Earth.

At Hexoskin, since we started working with Canadian Space Agency in 2011, we designed medical monitoring systems with the goal of fulfilling the autonomy requirements of future missions to the Moon and Mars. The spillover effects of space exploration projects are applicable beyond human spaceflight and find applications on earth that benefit humanity.

The technologies we're developing will allow a greater number of people to access regular care, especially patients with chronic cardiovascular and respiratory diseases. The software being developed for medical autonomous systems has the potential to deliver automated health services, affordable and accessible 24/7.

After today's announcement, we hope that Hexoskin will be able to contribute to future missions to the Moon, by supplying innovative medical technologies for crew members taking the trip.

Live Webinar - Join Us for the upcoming Hexoskin Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin

Join Us for our Hexoskin Live Webinar on February 27th! 

We invite you to attend our Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin, that will cover the latest fields of applications & research studies. Our guest speaker, Thomas Beltrame, PhD, will discuss his work with his fellow research team at University of Waterloo to evaluate cardiovascular & respiratory health with Hexoskin and machine learning.

We will also present how the Hexoskin and Astroskin end-to-end platforms can support research and professional organizations for their Machine Learning & Artificial Intelligence projects.

HEXOSKIN LIVE WEBINAR:
Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin
Wednesday, February 27, 2019, at 12:00 PM (EST) - via the Zoom Video Conferencing software

Speakers: 
Pierre-Alexandre Fournier
CEO & Co-Founder, Hexoskin

Thu Ngan Trinh PhD
Clinical Applications Specialist, Hexoskin

Guest Speaker: 
Thomas Beltrame PhD
Department of Physiotherapy - Federal University of São Carlos
Institute of Computing - University of Campinas

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward. 

We look forward to your presence for this special event!

Deployment of the Bio-Monitor in Space by Canadian Space Agency Astronaut David Saint-Jacques (CSA)

This week, Canadian Space Agency Astronaut David Saint-Jacques deployed and tested for the first time in space a new Canadian technology: the Bio-Monitor System.

This advanced smart shirt is designed to measure and record vital signs in microgravity environment. It will help keep an eye on astronauts' health and enable medical research in space by continuously measuring physiological data.

The Canadian Space Agency's Bio-Monitor is designed to easily send information to the ground, where scientists can monitor astronauts' physiology around the clock as they orbit the planet. Once operational it will be available for the next five years to all participating countries to the International Space Station.

To learn more: http://asc-csa.gc.ca/eng/missions/expedition58/default.asp.
Photo: CSA/NASA

Astroskin / Bio-Monitor Successfully Launched to Space aboard Space X Dragon Spacecraft

Launch successful! En route to the International Space Station! The Bio-Monitor Astroskin system is part of the payload that was launched today in a Dragon spacecraft on a Falcon 9 rocket from Cape Canaveral, Florida.

About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space. To learn more on Astroskin Vital Signs Monitoring Platform download Astroskin Product Specifications document. 
Contact our team to order Astroskin

Live Webcast - Join Us for the Bio-Monitor (Astroskin) launch to Space on December 4th!

We are happy to invite you to our live webcast on December 4th, that will broadcast the Astroskin launch to Space aboard Space X Dragon Cargo vehicle. Before the launch, Hexoskin's co-founders will discuss the history of the development of the Bio-Monitor system as well as a few case applications in Space and on Earth.

The Astroskin system is based on the Bio-Monitor designed for the Canadian Space Agency (CSA) to monitor the astronauts’ health in space on the International Space Station (ISS). It will be operational in space and available for all ISS participating countries to conduct space research for the next five years.
 
LIVE WEBCAST:
Astroskin Launch to the ISS aboard SpaceX Dragon Cargo
December 4, 2018, at 1:25 PM (EST)** - via the Zoom Video Conferencing software
** In case of postponement of the launch, you will receive a notification
with a new broadcast schedule.

Speakers: 
- Pierre-Alexandre Fournier, CEO & Co-Founder, Hexoskin
- Jean-François Roy, CTO & Co-Founder, Hexoskin 

Guest Speaker: 
- Professor Richard L. Hughson Ph.D., University of Waterloo

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward. 

We look forward to your presence for this special event!

About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.

Contact our team to order Astroskin

Introducing the New Hexoskin Dashboard

We are introducing a new Dashboard to improve your experience with Hexoskin. You can now monitor your health closely, share your data or manage groups of users efficiently with advanced functionalities requested by our user community.

This dashboard completes our ever-evolving Hexoskin Connected Health Platform. Here are a few features that you should try today!

The Bio-Monitor to launch to the International Space Station

The Bio-Monitor, designed by Hexoskin for the Canadian Space Agency (CSA) to monitor the Astronauts' Health in Space aboard the International Space Station (ISS) is finally launching to Space! The Bio-Monitor System is scheduled to launch aboard a SpaceX Dragon cargo spacecraft on December 4, 2018, at Cape Canaveral Air Force Station in Florida.

David Saint-Jacques will be the next Canadian astronaut to live in the ISS. His first mission to the ISS is scheduled to launch on December 3, 2018. David Saint-Jacques will be conducting tests and experiments with the Bio-Monitor platform.

Last week, the Canadian Space Agency announced the award of an additional contract to Carré Technologies (Hexoskin). The Hexoskin team is excited to continue an adventure that started in 2011 with the Canadian Space Agency and wishes the best of luck the astronaut David Saint-Jacques for his mission.

Learn more at:
http://www.asc-csa.gc.ca/eng/sciences/bio-monitor.asp

About Hexoskin:
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Hexoskin’s provide solutions and services directly to customers & athletes; and through B2B contracts in security, defense & aerospace agencies, pharmaceutical companies, academics, and healthcare organizations. 

Hexoskin obtained its first contract from the Canadian Space Agency in October 2011. The Bio-Monitor demonstrates once again Hexoskin’s leadership in providing industry-leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.  

In September 2018, Hexoskin launched the Astroskin Research Platform to support various projects and health research on earth. The Astroskin is based on the Bio-Monitor and is further adapted to be used on earth. Astroskin offers an end-to-end platform to collect real-world evidence with space-grade garments that include sensors embedded in the fabric such as a 3-lead electrocardiogram, breathing sensors, pulse oximeter, blood pressure, skin temperature, and activity sensors.

Contact us to order Astroskin for your project.

Hexoskin - AI Applications Summit Biopharma Boston

Our team will attend the AI Applications Summit Biopharma in Boston this week (October 25-26).

Hexoskin was founded in 2006 to develop sensors and information systems to support Artificial Intelligence applications for clinical research and healthcare. Over the years, we've worked with many organisations to develop systems to make a better use of clinical data, and we've learned a few things from it:

• Great AI needs great data: data collection is the foundation of all AI work.
• 90% of AI work is in processing and annotating data. AI modeling is the "easy" part.
• Define valuable endpoints first, then define how to collect the relevant data to build your models.
• When using connected devices and mobile devices for data collection, design a patient-centric pilot trial first to validate human factor assumptions.

There's a lot more to know to operationalize AI projects in clinical trials of course. Even when working with a technological partner, you'll need to have people in your team with the skills to manage the digital component of the project. Please reach out to us if you need advice on best practices and operations.

In short, there's a lot of opportunity for AI in clinical trials, from patient recrutement to data modeling, including virtual trials and phase IV trials. We're looking forward to share insights with you in Boston this week!

---

Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.

Using Wearables, Data, and AI in Clinical Trials

Montréal InVivo hosted an event today in Laval, Québec, to discuss the use of data and AI in clinical trials. Representatives from Alta Sciences, a CRO focused on phase I/II trials in Canada and the US, and Accreon (Health IT), joined Hexoskin to discuss strategies and best practices.

On the picture below you can see Marc Paquin, Director of Partnerships and Business Development, sharing Hexoskin's experience with wearable sensors & AI software development for clinical trials.

Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.

Hexoskin at the MedTech conference in Philadelphia on September 23-26, 2018!

Hexoskin is attending again the MedTech conference this week on September 23-26, 2018!

The Hexoskin Team will be meeting with stakeholders from the MedTech industry and showcase its solutions and expertise for monitoring patients with chronic diseases. Hexoskin is part of the Quebec Delegation organized by the Quebec Government.

If your company is interested in digital markers, sensors and AI in healthcare, book a meeting with our team here!

For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.